Vascular inflammation in central nervous system diseases: Adhesion receptors controlling leukocyte-endothelial interactions

Journal of Leukocyte Biology

Volumn 89, Issue 4, 2011, Pages 539-556

  Rossi, Barbara ^a   Angiari, Stefano ^a   Zenaro, Elena ^a   Budui, Simona Luciana ^a   Constantin, Gabriela ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Alzheimer's disease; Epilepsy; Integrins; Multiple sclerosis; Selectins; Stroke

Indexed keywords

ALPHA4BETA7 INTEGRIN; ALPHALBETA2 INTEGRIN; ALPHAMBETA2 INTEGRIN; CELL ADHESION MOLECULE; CELL RECEPTOR; CHEMOATTRACTANT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTEGRIN; L SELECTIN; PADGEM PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4;

ALZHEIMER DISEASE; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL INTERACTION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC INFLAMMATION; ENCEPHALOMYELITIS; ENDOTHELIUM CELL; EPILEPSY; HUMAN; INFLAMMATION; LEUKOCYTE; LEUKOCYTE MIGRATION; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEIZURE;

ANIMALS; CELL ADHESION; CENTRAL NERVOUS SYSTEM DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOCYTES; MEMBRANE GLYCOPROTEINS; VASCULAR DISEASES;

ANIMALIA;

EID: 79953701030     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0710432     Document Type: Review

References (285)

1. Butcher, E. C. (1991) Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67, 1033-1036.
2. Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
3. Luster, A. D., Alon, R., von Andrian, U. H. (2005) Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6, 1182-1190.
4. Ley, K., Laudanna, C., Cybulsky, M. I., Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689.
5. Bechmann, I., Galea, I., Perry, V. H. (2007) What is the blood-brain barrier (not)? Trends Immunol. 28, 5-11.
6. Galea, I., Bechmann, I., Perry, V. H. (2007) What is immune privilege (not)? Trends Immunol. 28, 12-18.
7. Ballabh, P., Braun, A., Nedergaard, M. (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13.
8. Abbott, N. J., Ronnback, L., Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53.
9. Ley, K., Kansas, G. S. (2004) Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat. Rev. Immunol. 4, 325-335.
10. Butcher, E. C., Williams, M., Youngman, K., Rott, L., Briskin, M. (1999) Lymphocyte trafficking and regional immunity. Adv. Immunol. 72, 209-253.
11. Rosen, S. D. (2004) Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22, 129-156.
12. Eriksson, E. E., Xie, X., Werr, J., Thoren, P., Lindbom, L. (2001) Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. J. Exp. Med. 194, 205-218.
13. Sperandio, M., Smith, M. L., Forlow, S. B., Olson, T. S., Xia, L., McEver, R. P., Ley, K. (2003) P-selectin glycoprotein ligand-1 mediates L-selectindependent leukocyte rolling in venules. J. Exp. Med. 197, 1355-1363.
14. Rivera-Nieves, J., Burcin, T. L., Olson, T. S., Morris, M. A., McDuffie, M., Cominelli, F., Ley, K. (2006) Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J. Exp. Med. 203, 907-917.
15. Eppihimer, M. J., Russell, J., Anderson, D. C., Wolitzky, B. A., Granger, D. N. (1997) Endothelial cell adhesion molecule expression in genetargeted mice. Am. J. Physiol. 273, H1903-H1908.
16. Kivisäkk, P., Mahad, D. J., Callahan, M. K., Trebst, C., Tucky, B., Wei, T., Wu, L., Baekkevold, E. S., Lassmann, H., Staugaitis, S. M., Campbell, J. J., Ransohoff, R. M. (2003) Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. USA 100, 8389-8394.
17. Keelan, E. T., Licence, S. T., Peters, A. M., Binns, R. M., Haskard, D. O. (1994) Characterization of E-selectin expression in vivo with use of a radiolabeled monoclonal antibody. Am. J. Physiol. 266, H278-H290.
18. Kansas, G. S. (1996) Selectins and their ligands: current concepts and controversies. Blood 88, 3259-3287.
19. Ley, K. (2003) The role of selectins in inflammation and disease. Trends Mol. Med. 9, 263-268.
20. Constantin, G. (2004) PSGL-1 as a novel therapeutic target. Drug News Perspect. 17, 579-586.
21. Katayama, Y., Hidalgo, A., Chang, J., Peired, A., Frenette, P. S. (2005) CD44 is a physiological E-selectin ligand on neutrophils. J. Exp. Med. 201, 1183-1189.
22. Hidalgo, A., Peired, A. J., Wild, M. K., Vestweber, D., Frenette, P. S. (2007) Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 26, 477-489.
23. Sigal, A., Bleijs, D. A., Grabovsky, V., van Vliet, S. J., Dwir, O., Figdor, C. G., van Kooyk, Y., Alon, R. (2000) The LFA-1 integrin supports rolling adhesions on ICAM-1 under physiological shear flow in a permissive cellular environment. J. Immunol. 165, 442-452.
24. Ibbotson, G. C., Doig, C., Kaur, J., Gill, V., Ostrovsky, L., Fairhead, T., Kubes, P. (2001) Functional α4-integrin: a newly identified pathway of neutrophil recruitment in critically ill septic patients. Nat. Med. 7, 465-470.
25. Butcher, E. C. (2005) The multistep model of leukocyte recruitment: a personal perspective from 15 year later. In Leukocyte Trafficking (A. E. Haman, ed.), Germany, Wiley-VCH, 3-13.
26. McEver, R. P. (2005) A sulfated address for lymphocyte homing. Nat. Immunol. 6, 1067-1069.
27. Piccio, L., Rossi, B., Scarpini, E., Laudanna, C., Giagulli, C., Issekutz, A. C., Vestweber, D., Butcher, E. C., Constantin, G. (2002) Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J. Immunol. 168, 1940-1949.
28. Piccio, L., Rossi, B., Colantonio, L., Grenningloh, R., Gho, A., Ottoboni, L., Homeister, J. W., Scarpini, E., Martinello, M., Laudanna, C., D'Ambrosio, D., Lowe, J. B., Constantin, G. (2005) Efficient recruitment of lymphocytes in inflamed brain venules requires expression of cutaneous lymphocyte antigen and fucosyltransferase-VII. J. Immunol. 174, 5805-5813.
29. Siegelman, M. H., Stanescu, D., Estess, P. (2000) The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion. J. Clin. Invest. 105, 683-691.
30. Nandi, A., Estess, P., Siegelman, M. (2004) Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation. Immunity 20, 455-465.
31. Wang, H. B., Wang, J. T., Zhang, L., Geng, Z. H., Xu, W. L., Xu, T., Huo, Y., Zhu, X., Plow, E. F., Chen, M., Geng, J. G. (2007) P-selectin primes leukocyte integrin activation during inflammation. Nat. Immunol. 8, 882-892.
32. Rose, D. M., Alon, R., Ginsberg, M. H. (2007) Integrin modulation and signaling in leukocyte adhesion and migration. Immunol. Rev. 218, 126-134.
33. Steinman, L. (2009) A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 9, 440-447.
34. Laudanna, C., Mochly-Rosen, D., Liron, T., Constantin, G., Butcher, E. C. (1998) Evidence of ζ protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J. Biol. Chem. 273, 30306-30315.
35. Laudanna, C., Kim, J. Y., Constantin, G., Butcher, E. (2002) Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186, 37-46.
36. Zimmerman, G. A., McIntyre, T. M. (1988) Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mo1, MAC-1/LFA-1/GP 150,95) glycoprotein-dependent and-independent mechanisms. J. Clin. Invest. 81, 531-537.
37. Goodarzi, K., Goodarzi, M., Tager, A. M., Luster, A. D., von Andrian, U. H. (2003) Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4, 965-973.
38. Tager, A. M., Bromley, S. K., Medoff, B. D., Islam, S. A., Bercury, S. D., Friedrich, E. B., Carafone, A. D., Gerszten, R. E., Luster, A. D. (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4, 982-990.
39. Ledgerwood, L. G., Lal, G., Zhang, N., Garin, A., Esses, S. J., Ginhoux, F., Merad, M., Peche, H., Lira, S. A., Ding, Y., Yang, Y., He, X., Schuchman, E. H., Allende, M. L., Ochando, J. C., Bromberg, J. S. (2008) The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat. Immunol. 9, 42-53.
40. Price, C. J., Warburton, E. A., Menon, D. K. (2003) Human cellular inflammation in the pathology of acute cerebral ischemia. J. Neurol. Neurosurg. Psychiatry 74, 1476-1484.
41. Lo, E. H., Dalkara, T., Moskowitz, M. A. (2003) Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415.
42. Dirnagl, U., Iadecola, C., Moskowitz, M. A. (1999) Pathobiology of ischemic stroke: an integrated view. Trends Neurosci. 22, 391-397.
43. Fisher, M. (2004) The ischemic penumbra: identification, evolution and treatment concepts. Cerebrovasc. Dis. 17 (Suppl. 1), 1-6.
44. Shichita, T., Sugiyama, Y., Ooboshi, H., Sugimori, H., Nakagawa, R., Takada, I., Iwaki, T., Okada, Y., Iida, M., Cua, D. J., Iwakura, Y., Yoshimura, A. (2009) Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury. Nat. Med. 15, 946-950.
45. Zhang, R., Chopp, M., Zhang, Z., Jiang, N., Powers, C. (1998) The expression of P-and E-selectins in three models of middle cerebral artery occlusion. Brain Res. 785, 207-214.
46. Huang, J., Choudhri, T. F., Winfree, C. J., McTaggart, R. A., Kiss, S., Mocco, J., Kim, L. J., Protopsaltis, T. S., Zhang, Y., Pinsky, D. J., Connolly Jr., E. S. (2000) Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke 31, 3047-3053.
47. Connolly Jr., E. S., Winfree, C. J., Prestigiacomo, C. J., Kim, S. C., Choudhri, T. F., Hoh, B. L., Naka, Y., Solomon, R. A., Pinsky, D. J. (1997) Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ. Res. 81, 304-310.
48. Frijns, C. J., Kappelle, L. J., van Gijn, J., Nieuwenhuis, H. K., Sixma, J. J., Fijnheer, R. (1997) Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 28, 2214-2218.
49. Fassbender, K., Mossner, R., Motsch, L., Kischka, U., Grau, A., Hennerici, M. (1995) Circulating selectin-and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 26, 1361-1364.
50. Shyu, K. G., Chang, H., Lin, C. C. (1997) Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischemic stroke. J. Neurol. 244, 90-93.
51. Bitsch, A., Klene, W., Murtada, L., Prange, H., Rieckmann, P. (1998) A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke 29, 2129-2135.
52. Kisucka, J., Chauhan, A. K., Zhao, B. Q., Patten, I. S., Yesilaltay, A., Krieger, M., Wagner, D. D. (2009) Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 113, 6015-6022.
53. Woollard, K. J., Kling, D., Kulkarni, S., Dart, A. M., Jackson, S., Chin-Dusting, J. (2006) Raised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion. Circ. Res. 98, 149-156.
54. Goussev, A. V., Zhang, Z., Anderson, D. C., Chopp, M. (1998) P-selectin antibody reduces hemorrhage and infarct volume resulting from MCA occlusion in the rat. J. Neurol. Sci. 161, 16-22.
55. Jin, A. Y., Tuor, U. I., Rushforth, D., Kaur, J., Muller, R. N., Petterson, J. L., Boutry, S., Barber, P. A. (2010) Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke. BMC Neurosci. 11, 12.
56. Huang, J., Kim, L. J., Mealey, R., Marsh Jr., H. C., Zhang, Y., Tenner, A. J., Connolly Jr., E. S., Pinsky, D. J. (1999) Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285, 595-599.
57. Zhang, R. L., Chopp, M., Zhang, Z. G., Phillips, M. L., Rosenbloom, C. L., Cruz, R., Manning, A. (1996) E-selectin in focal cerebral ischemia and reperfusion in the rat. J. Cereb. Blood Flow Metab. 16, 1126-1136.
58. Mocco, J., Choudhri, T., Huang, J., Harfeldt, E., Efros, L., Klingbeil, C., Vexler, V., Hall, W., Zhang, Y., Mack, W., Popilskis, S., Pinsky, D. J., Connolly Jr., E. S. (2002) HuEP5C7 as a humanized monoclonal anti-E/ P-selectin neurovascular protective strategy in a blinded placebo-controlled trial of nonhuman primate stroke. Circ. Res. 91, 907-914.
59. Chen, Y., Ruetzler, C., Pandipati, S., Spatz, M., McCarron, R. M., Becker, K., Hallenbeck, J. M. (2003) Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc. Natl. Acad. Sci. USA 100, 15107-15112.
60. Takeda, H., Spatz, M., Ruetzler, C., McCarron, R., Becker, K., Hallenbeck, J. (2002) Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats. Stroke 33, 2156-2163.
61. Yun, W., Qing-Cheng, L., Lei, Y., Jia-Yin, M. (2008) Mucosal tolerance to E-selectin provides protection against cerebral ischemia-reperfusion injury in rats. J. Neuroimmunol. 205, 73-79.
62. Yenari, M. A., Sun, G. H., Kunis, D. M., Onley, D., Vexler, V. (2001) Lselectin inhibition does not reduce injury in a rabbit model of transient focal cerebral ischemia. Neurol. Res. 23, 72-78.
63. Rossi, B., Constantin, G. (2008) Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm. Allergy Drug Targets 7, 85-93.
64. Wang, X., Siren, A. L., Liu, Y., Yue, T. L., Barone, F. C., Feuerstein, G. Z. (1994) Upregulation of intercellular adhesion molecule 1 (ICAM-1) on brain microvascular endothelial cells in rat ischemic cortex. Brain Res. Mol. Brain Res. 26, 61-68.
65. Zhang, R. L., Chopp, M., Zaloga, C., Zhang, Z. G., Jiang, N., Gautam, S. C., Tang, W. X., Tsang, W., Anderson, D. C., Manning, A. M. (1995) The temporal profiles of ICAM-1 protein and mRNA expression after transient MCA occlusion in the rat. Brain Res. 682, 182-188.
66. Bowes, M. P., Zivin, J. A., Rothlein, R. (1993) Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp. Neurol. 119, 215-219.
67. Chopp, M., Li, Y., Jiang, N., Zhang, R. L., Prostak, J. (1996) Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J. Cereb. Blood Flow Metab. 16, 578-584.
68. Clark, W. M., Madden, K. P., Rothlein, R., Zivin, J. A. (1991) Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. 75, 623-627.
69. Kanemoto, Y., Nakase, H., Akita, N., Sakaki, T. (2002) Effects of antiintercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model. Neurosurgery 51, 1034-1041.
70. Vemuganti, R., Dempsey, R. J., Bowen, K. K. (2004) Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat. Stroke 35, 179-184.
71. Soriano, S. G., Lipton, S. A., Wang, Y. F., Xiao, M., Springer, T. A., Gutierrez-Ramos, J. C., Hickey, P. R. (1996) Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann. Neurol. 39, 618-624.
72. Connolly Jr., E. S., Winfree, C. J., Springer, T. A., Naka, Y., Liao, H., Yan, S. D., Stern, D. M., Solomon, R. A., Gutierrez-Ramos, J. C., Pinsky, D. J. (1996) Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209-216.
73. Kitagawa, K., Matsumoto, M., Mabuchi, T., Yagita, Y., Ohtsuki, T., Hori, M., Yanagihara, T. (1998) Deficiency of intercellular adhesion molecule1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 18, 1336-1345.
74. Justicia, C., Martin, A., Rojas, S., Gironella, M., Cervera, A., Panes, J., Chamorro, A., Planas, A. M. (2006) Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J. Cereb. Blood Flow Metab. 26, 421-432.
75. Chen, H., Chopp, M., Zhang, R. L., Bodzin, G., Chen, Q., Rusche, J. R., Todd III, R. F. (1994) Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 35, 458-463.
76. Bowes, M. P., Rothlein, R., Fagan, S. C., Zivin, J. A. (1995) Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy. Neurology 45, 815-819.
77. Clark, W. M., Madden, K. P., Rothlein, R., Zivin, J. A. (1991) Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 22, 877-883.
78. Zhang, R. L., Zhang, Z. G., Chopp, M. (1999) Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat. Neurology 52, 273-279.
79. Bednar, M. M., Wright, S. D., Raymond-Russell, S. J., Kohut, J. J., Gross, C. E. (1996) IB4, a monoclonal antibody against the CD18 leukocyte adhesion protein, reduces intracranial pressure following thromboembolic stroke in the rabbit. Neurol. Res. 18, 171-175.
80. Yenari, M. A., Kunis, D., Sun, G. H., Onley, D., Watson, L., Turner, S., Whitaker, S., Steinberg, G. K. (1998) Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia. Exp. Neurol. 153, 223-233.
81. Chopp, M., Zhang, R. L., Chen, H., Li, Y., Jiang, N., Rusche, J. R. (1994) Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25, 869-875.
82. Garcia, J. H., Liu, K. F., Bree, M. P. (1996) Effects of CD11b/18 monoclonal antibody on rats with permanent middle cerebral artery occlusion. Am. J. Pathol. 148, 241-248.
83. Prestigiacomo, C. J., Kim, S. C., Connolly Jr., E. S., Liao, H., Yan, S. F., Pinsky, D. J. (1999) CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. Stroke 30, 1110-1117.
84. Soriano, S. G., Coxon, A., Wang, Y. F., Frosch, M. P., Lipton, S. A., Hickey, P. R., Mayadas, T. N. (1999) Mice deficient in Mac-1 (CD11b/ CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 30, 134-139.
85. Matsuo, Y., Onodera, H., Shiga, Y., Shozuhara, H., Ninomiya, M., Kihara, T., Tamatani, T., Miyasaka, M., Kogure, K. (1994) Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656, 344-352.
86. Becker, K., Kindrick, D., Relton, J., Harlan, J., Winn, R. (2001) Antibody to the α4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32, 206-211.
87. Matsumoto, T., Ikeda, K., Mukaida, N., Harada, A., Matsumoto, Y., Yamashita, J., Matsushima, K. (1997) Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab. Invest. 77, 119-125.
88. Kim, J. S., Gautam, S. C., Chopp, M., Zaloga, C., Jones, M. L., Ward, P. A., Welch, K. M. (1995) Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J. Neuroimmunol. 56, 127-134.
89. Hughes, P. M., Allegrini, P. R., Rudin, M., Perry, V. H., Mir, A. K., Wiessner, C. (2002) Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J. Cereb. Blood Flow Metab. 22, 308-317.
90. Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F., Andjelkovic, A. V. (2007) Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38, 1345-1353.
91. Jiang, L., Newman, M., Saporta, S., Chen, N., Sanberg, C., Sanberg, P. R., Willing, A. E. (2008) MIP-1α and MCP-1 induce migration of human umbilical cord blood cells in models of stroke. Curr. Neurovasc. Res. 5, 118-124.
92. Schönemeier, B., Schulz, S., Hoellt, V., Stumm, R. (2008) Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J. Neuroimmunol. 198, 39-45.
93. Bona, E., Andersson, A. L., Blomgren, K., Gilland, E., Puka-Sundvall, M., Gustafson, K., Hagberg, H. (1999) Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr. Res. 45, 500-509.
94. Wang, X., Li, X., Schmidt, D. B., Foley, J. J., Barone, F. C., Ames, R. S., Sarau, H. M. (2000) Identification and molecular characterization of rat CXCR3: receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Mol. Pharmacol. 57, 1190-1198.
95. Barone, F. C., Schmidt, D. B., Hillegass, L. M., Price, W. J., White, R. F., Feuerstein, G. Z., Clark, R. K., Lee, E. V., Griswold, D. E., Sarau, H. M. (1992) Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke 23, 1337-1347.
96. Patcha, V., Wigren, J., Winberg, M. E., Rasmusson, B., Li, J., Särndahl, E. (2004) Differential inside-out activation of β2-integrins by leukotriene B4 and fMLP in human neutrophils. Exp. Cell Res. 300, 308-319.
97. Carnini, C., Constantin, G., Rossi, B., De Curtis, M., Folco, G. (2003) Firm adhesion of neutrophils to cerebral vascular endothelium "in vivo": a role for cys-leukotrienes. Adv. Exp. Med. Biol. 525, 35-38.
98. Di Gennaro, A., Carnini, C., Buccellati, C., Ballerio, R., Zarini, S., Fumagalli, F., Viappiani, S., Librizzi, L., Hernandez, A., Murphy, R. C., Constantin, G., De Curtis, M., Folco, G., Sala, A. (2004) Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J. 18, 842-844.
99. Meliton, A. Y., Muñoz, N. M., Osan, C. M., Meliton, L. N., Leff, A. R. (2010) Leukotriene D4 activates β2-integrin adhesion in human polymorphonuclear leukocytes. Eur. Respir. J. 35, 402-409.
100. Aspey, B. S., Alp, M. S., Patel, Y., Harrison, M. J. (1997) Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischemia-an initial screening study. Metab. Brain Dis. 12, 237-249.
101. Belayev, L., Khoutorova, L., Atkins, K., Gordon, W. C., Alvarez-Builla, J., Bazan, N. G. (2008) LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. Exp. Neurol. 214, 253-258.
102. Hamada, K., Nakamura, H., Oda, T., Hirano, T., Shimizu, N., Utiyama, H. (1998) Involvement of Mac-1-mediated adherence and sphingosine 1-phosphate in survival of phorbol ester-treated U937 cells. Biochem. Biophys. Res. Commun. 244, 745-750.
103. Czech, B., Pfeilschifter, W., Mazaheri-Omrani, N., Strobel, M. A., Kahles, T., Neumann-Haefelin, T., Rami, A., Huwiler, A., Pfeilschifter, J. (2009) The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem. Biophys. Res. Commun. 389, 251-256.
104. Hasegawa, Y., Suzuki, H., Sozen, T., Rolland, W., Zhang, J. H. (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41, 368-374.
105. Hyman, M. C., Petrovic-Djergovic, D., Visovatti, S. H., Liao, H., Yanamadala, S., Bouis, D., Su, E. J., Lawrence, D. A., Broekman, M. J., Marcus, A. J., Pinsky, D. J. (2009) Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J. Clin. Invest. 119, 1136-1149.
106. Iwanaga, Y., Ueno, M., Ueki, M., Huang, C. L., Tomita, S., Okamoto, Y., Ogawa, T., Ueda, N., Maekawa, N., Sakamoto, H. (2008) The expression of osteopontin is increased in vessels with blood-brain barrier impairment. Neuropathol. Appl. Neurobiol. 34, 145-154.
107. Doyle, K. P., Yang, T., Lessov, N. S., Ciesielski, T. M., Stevens, S. L., Simon, R. P., King, J. S., Stenzel-Poore, M. P. (2008) Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. J. Cereb. Blood Flow Metab. 28, 1235-1248.
108. Tsai, N. W., Chang, W. N., Shaw, C. F., Jan, C. R., Huang, C. R., Chen, S. D., Chuang, Y. C., Lee, L. H., Lu, C. H. (2009) The value of leukocyte adhesion molecules in patients after ischemic stroke. J. Neurol. 256, 1296-1302.
109. Lindsberg, P. J., Carpen, O., Paetau, A., Karjalainen-Lindsberg, M. L., Kaste, M. (1996) Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94, 939-945.
110. Clark, W. M., Coull, B. M., Briley, D. P., Mainolfi, E., Rothlein, R. (1993) Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke. J. Neuroimmunol. 44, 123-125.
111. Ehrensperger, E., Minuk, J., Durcan, L., Mackey, A., Wolfson, C., Fontaine, A. M., Cote, R. (2005) Predictive value of soluble intercellular adhesion molecule-1 for risk of ischemic events in individuals with cerebrovascular disease. Cerebrovasc. Dis. 20, 456-462.
112. Selaković, V., Colić, M., Jovanović, M., Raicević, R., Jovicić, A. (2003) Cerebrospinal fluid and plasma concentration of soluble intercellular adhesion molecule 1, vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule in patients with acute ischemic brain disease. Vojnosanit. Pregl. 60, 139-146.
113. Simundic, A. M., Basic, V., Topic, E., Demarin, V., Vrkic, N., Kunovic, B., Stefanovic, M., Begonja, A. (2004) Soluble adhesion molecules in acute ischemic stroke. Clin. Invest. Med. 27, 86-92.
114. Vuorte, J., Lindsberg, P. J., Kaste, M., Meri, S., Jansson, S. E., Rothlein, R., Repo, H. (1999) Anti-ICAM-1 monoclonal antibody R6.5 (enlimomab) promotes activation of neutrophils in whole blood. J. Immunol. 162, 2353-2357.
115. Furuya, K., Takeda, H., Azhar, S., McCarron, R. M., Chen, Y., Ruetzler, C. A., Wolcott, K. M., DeGraba, T. J., Rothlein, R., Hugli, T. E., del Zoppo, G. J., Hallenbeck, J. M. (2001) Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke 32, 2665-2674.
116. Faxon, D. P., Gibbons, R. J., Chronos, N. A., Gurbel, P. A., Sheehan, F. (2002) The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J. Am. Coll. Cardiol. 40, 1199-1204.
117. Becker, K. J. (2002) Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and enlimomab (R6.5) in acute stroke. Curr. Med. Res. Opin. 18 (Suppl. 2), s18-s22.
118. Krams, M., Lees, K. R., Hacke, W., Grieve, A. P., Orgogozo, J. M., Ford, G. A. (2003) Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 34, 2543-2548.
119. Marski, M., Kandula, S., Turner, J. R., Abraham, C. (2005) CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J. Immunol. 175, 7889-7897.
120. Wohler, J., Bullard, D., Schoeb, T., Barnum, S. (2009) LFA-1 is critical for regulatory T cell homeostasis and function. Mol. Immunol. 46, 2424-2428.
121. Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., Veltkamp, R. (2009) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192-199.
122. McFarland, H. F., Martin, R. (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919.
123. Stone, L. A., Smith, M. E., Albert, P. S., Bash, C. N., Maloni, H., Frank, J. A., McFarland, H. F. (1995) Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 45, 1122-1126.
124. Lassmann, H., Wisniewski, H. M. (1978) Chronic relapsing EAE. Time course of neurological symptoms and pathology. Acta Neuropathol. 43, 35-42.
125. Traugott, U., Raine, C. S. (1979) Acute experimental allergic encephalomyelitis. Myelin basic protein-reactive T cells in the circulation and in meningeal infiltrates. J. Neurol. Sci. 42, 331-336.
126. Tsuchida, M., Hanawa, H., Hirahara, H., Watanabe, H., Matsumoto, Y., Sekikawa, H., Abo, T. (1994) Identification of CD4-CD8-α β T cells in the subarachnoid space of rats with experimental autoimmune encephalomyelitis. A possible route by which effector cells invade the lesions. Immunology 81, 420-427.
127. Ransohoff, R. M., Kivisakk, P., Kidd, G. (2003) Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3, 569-581.
128. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A., Lanzavecchia, A., Engelhardt, B., Sallusto, F. (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10, 514-523.
129. Brown, D. A., Sawchenko, P. E. (2007) Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J. Comp. Neurol. 502, 236-260.
130. Bartholomäus, I., Kawakami, N., Odoardi, F., Schlager, C., Miljkovic, D., Ellwart, J. W., Klinkert, W. E., Flugel-Koch, C., Issekutz, T. B., Wekerle, H., Flugel, A. (2009) Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462, 94-98.
131. Allt, G., Lawrenson, J. G. (1997) Is the pial microvessel a good model for blood-brain barrier studies? Brain Res. Brain Res. Rev. 24, 67-76.
132. Goverman, J. (2009) Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407.
133. Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., Prat, A. (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173-1175.
134. Carson, M. J., Reilly, C. R., Sutcliffe, J. G., Lo, D. (1999) Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. Am. J. Pathol. 154, 481-494.
135. Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Ohlen, C., Goverman, J. (2001) A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194, 669-676.
136. Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., Raine, C. S. (2001) Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166, 7579-7587.
137. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schroder, R., Deckert, M., Schmidt, S., Ravid, R., Rajewsky, K. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192, 393-404.
138. Battistini, L., Piccio, L., Rossi, B., Bach, S., Galgani, S., Gasperini, C., Ottoboni, L., Ciabini, D., Caramia, M. D., Bernardi, G., Laudanna, C., Scarpini, E., McEver, R. P., Butcher, E. C., Borsellino, G., Constantin, G. (2003) CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for Pselectin glycoprotein ligand-1. Blood 101, 4775-4782.
139. Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Backstrom, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., Oukka, M., Kuchroo, V. K. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431.
140. Brabb, T., von Dassow, P., Ordonez, N., Schnabel, B., Duke, B., Goverman, J. (2000) In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192, 871-880.
141. Lee, S. J., Benveniste, E. N. (1999) Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 98, 77-88.
142. Kuenz, B., Lutterotti, A., Khalil, M., Ehling, R., Gneiss, C., Deisenhammer, F., Reindl, M., Berger, T. (2005) Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis. J. Neuroimmunol. 167, 143-149.
143. Bahbouhi, B., Berthelot, L., Pettre, S., Michel, L., Wiertlewski, S., Weksler, B., Romero, I. A., Miller, F., Couraud, P. O., Brouard, S., Laplaud, D. A., Soulillou, J. P. (2009) Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line. J. Leukoc. Biol. 86, 1049-1063.
144. Kerfoot, S. M., Kubes, P. (2002) Overlapping roles of P-selectin and α 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J. Immunol. 169, 1000-1006.
145. Kerfoot, S. M., Norman, M. U., Lapointe, B. M., Bonder, C. S., Zbytnuik, L., Kubes, P. (2006) Reevaluation of P-selectin and α 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J. Immunol. 176, 6225-6234.
146. Carrithers, M. D., Visintin, I., Kang, S. J., Janeway Jr., C. A. (2000) Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 123, 1092-1101.
147. Brennan, F. R., O'Neill, J. K., Allen, S. J., Butter, C., Nuki, G., Baker, D. (1999) CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology 98, 427-435.
148. Engelhardt, B., Vestweber, D., Hallmann, R., Schulz, M. (1997) E-and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 90, 4459-4472.
149. Döring, A., Wild, M., Vestweber, D., Deutsch, U., Engelhardt, B. (2007) E-and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J. Immunol. 179, 8470-8479.
150. Engelhardt, B., Kempe, B., Merfeld-Clauss, S., Laschinger, M., Furie, B., Wild, M. K., Vestweber, D. (2005) P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J. Immunol. 175, 1267-1275.
151. Osmers, I., Bullard, D. C., Barnum, S. R. (2005) PSGL-1 is not required for development of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 166, 193-196.
152. Bullard, D. C., Mobley, J. M., Justen, J. M., Sly, L. M., Chosay, J. G., Dunn, C. J., Lindsey, J. R., Beaudet, A. L., Staite, N. D. (1999) Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice. J. Immunol. 163, 2844-2849.
153. Huehn, J., Siegmund, K., Lehmann, J. C., Siewert, C., Haubold, U., Feuerer, M., Debes, G. F., Lauber, J., Frey, O., Przybylski, G. K., Niesner, U., de la Rosa, M., Schmidt, C. A., Brauer, R., Buer, J., Scheffold, A., Hamann, A. (2004) Developmental stage, phenotype, and migration distinguish naive-and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199, 303-313.
154. Siegmund, K., Feuerer, M., Siewert, C., Ghani, S., Haubold, U., Dankof, A., Krenn, V., Schon, M. P., Scheffold, A., Lowe, J. B., Hamann, A., Syrbe, U., Huehn, J. (2005) Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106, 3097-3104.
155. Urzainqui, A., Martinez del Hoyo, G., Lamana, A., de la Fuente, H., Barreiro, O., Olazabal, I. M., Martin, P., Wild, M. K., Vestweber, D., Gonzalez-Amaro, R., Sanchez-Madrid, F. (2007) Functional role of P-selectin glycoprotein ligand 1/P-selectin interaction in the generation of tolerogenic dendritic cells. J. Immunol. 179, 7457-7465.
156. Steffen, B. J., Butcher, E. C., Engelhardt, B. (1994) Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 145, 189-201.
157. Raine, C. S., Cannella, B., Duijvestijn, A. M., Cross, A. H. (1990) Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63, 476-489.
158. Giovannoni, G., Lai, M., Thorpe, J., Kidd, D., Chamoun, V., Thompson, A. J., Miller, D. H., Feldmann, M., Thompson, E. J. (1997) Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging. Neurology 48, 1557-1565.
159. Rieckmann, P., Martin, S., Weichselbraun, I., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer, W., Helwig, A., et al. (1994) Serial analysis of circulating adhesion molecules and TNF receptor in serum from patients with multiple sclerosis: cICAM-1 is an indicator for relapse. Neurology 44, 2367-2372.
160. Hartung, H. P., Reiners, K., Archelos, J. J., Michels, M., Seeldrayers, P., Heidenreich, F., Pflughaupt, K. W., Toyka, K. V. (1995) Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann. Neurol. 38, 186-193.
161. Rieckmann, P., Altenhofen, B., Riegel, A., Baudewig, J., Felgenhauer, K. (1997) Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann. Neurol. 41, 326-333.
162. Losy, J., Niezgoda, A., Wender, M. (1999) Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J. Neuroimmunol. 99, 169-172.
163. Vajkoczy, P., Laschinger, M., Engelhardt, B. (2001) α4-Integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 108, 557-565.
164. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., Karin, N. (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against α 4 β 1 integrin. Nature 356, 63-66.
165. Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., Janeway Jr., C. A. (1993) Surface expression of α 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177, 57-68.
166. Kent, S. J., Karlik, S. J., Cannon, C., Hines, D. K., Yednock, T. A., Fritz, L. C., Horner, H. C. (1995) A monoclonal antibody to α 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J. Neuroimmunol. 58, 1-10.
167. Keszthelyi, E., Karlik, S., Hyduk, S., Rice, G. P., Gordon, G., Yednock, T., Horner, H. (1996) Evidence for a prolonged role of α 4 integrin throughout active experimental allergic encephalomyelitis. Neurology 47, 1053-1059.
168. Theien, B. E., Vanderlugt, C. L., Eagar, T. N., Nickerson-Nutter, C., Nazareno, R., Kuchroo, V. K., Miller, S. D. (2001) Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 107, 995-1006.
169. Cannella, B., Cross, A. H., Raine, C. S. (1993) Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 46, 43-55.
170. Kobayashi, Y., Kawai, K., Honda, H., Tomida, S., Niimi, N., Tamatani, T., Miyasaka, M., Yoshikai, Y. (1995) Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. Cell. Immunol. 164, 295-305.
171. Gordon, E. J., Myers, K. J., Dougherty, J. P., Rosen, H., Ron, Y. (1995) Both anti-CD11a (LFA-1) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 62, 153-160.
172. Bullard, D. C., Hu, X., Schoeb, T. R., Axtell, R. C., Raman, C., Barnum, S. R. (2005) Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J. Immunol. 175, 6327-6333.
173. Kanwar, J. R., Kanwar, R. K., Wang, D., Krissansen, G. W. (2000) Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression. Immunol. Cell Biol. 78, 641-645.
174. Kanwar, J. R., Harrison, J. E., Wang, D., Leung, E., Mueller, W., Wagner, N., Krissansen, G. W. (2000) β7 Integrins contribute to demyelinating disease of the central nervous system. J. Neuroimmunol. 103, 146-152.
175. Constantin, G. (2008) Chemokine signaling and integrin activation in lymphocyte migration into the inflamed brain. J. Neuroimmunol. 198, 20-26.
176. Alt, C., Laschinger, M., Engelhardt, B. (2002) Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 32, 2133-2144.
177. Columba-Cabezas, S., Serafini, B., Ambrosini, E., Aloisi, F. (2003) Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol. 13, 38-51.
178. Krumbholz, M., Theil, D., Steinmeyer, F., Cepok, S., Hemmer, B., Hofbauer, M., Farina, C., Derfuss, T., Junker, A., Arzberger, T., Sinicina, I., Hartle, C., Newcombe, J., Hohlfeld, R., Meinl, E. (2007) CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J. Neuroimmunol. 190, 72-79.
179. McCandless, E. E., Wang, Q., Woerner, B. M., Harper, J. M., Klein, R. S. (2006) CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 177, 8053-8064.
180. Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisäkk, P., Ransohoff, R. M., Hofbauer, M., Farina, C., Derfuss, T., Hartle, C., Newcombe, J., Hohlfeld, R., Meinl, E. (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129, 200-211.
181. Dos Santos, A. C., Barsante, M. M., Arantes, R. M., Bernard, C. C., Teixeira, M. M., Carvalho-Tavares, J. (2005) CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis-an intravital microscopy study. J. Neuroimmunol. 162, 122-129.
182. Sørensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., Frederiksen, J. L., Ransohoff, R. M. (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103, 807-815.
183. Sørensen, T. L., Ransohoff, R. M., Strieter, R. M., Sellebjerg, F. (2004) Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur. J. Neurol. 11, 445-449.
184. Kivisäkk, P., Trebst, C., Liu, Z., Tucky, B. H., Sørensen, T. L., Rudick, R. A., Mack, M., Ransohoff, R. M. (2002) T-cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin. Exp. Immunol. 129, 510-518.
185. Friedrich, E. B., Tager, A. M., Liu, E., Pettersson, A., Owman, C., Munn, L., Luster, A. D., Gerszten, R. E. (2003) Mechanisms of leukotriene B4-triggered monocyte adhesion. Arterioscler. Thromb. Vasc. Biol. 23, 1761-1767.
186. Kihara, Y., Yokomizo, T., Kunita, A., Morishita, Y., Fukayama, M., Ishii, S., Shimizu, T. (2010) The leukotriene B4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitis. Biochem. Biophys. Res. Commun. 394, 673-678.
187. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., Foster, C. A., Zollinger, M., Lynch, K. R. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457.
188. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G. J., Card, D., Keohane, C., Rosenbach, M., Hale, J., Lynch, C. L., Rupprecht, K., Parsons, W., Rosen, H. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349.
189. Pabst, O., Herbrand, H., Willenzon, S., Worbs, T., Schippers, A., Mü ller, W., Bernhardt, G., Förster, R. (2006) Enhanced FTY720-mediated lymphocyte homing requires G α i signaling and depends on β 2 and β 7 integrin. J. Immunol. 176, 1474-1480.
190. Webb, M., Tham, C. S., Lin, F. F., Lariosa-Willingham, K., Yu, N., Hale, J., Mandala, S., Chun, J., Rao, T. S. (2004) Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J. Neuroimmunol. 153, 108-121.
191. Chi, H., Flavell, R. A. (2005) Cutting edge: regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1. J. Immunol. 174, 2485-2488.
192. Kataoka, H., Sugahara, K., Shimano, K., Teshima, K., Koyama, M., Fukunari, A., Chiba, K. (2005) FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration. Cell. Mol. Immunol. 2, 439-448.
193. Miron, V. E., Schubart, A., Antel, J. P. (2008) Central nervous systemdirected effects of FTY720 (fingolimod). J. Neurol. Sci. 274, 13-17.
194. Foster, C. A., Mechtcheriakova, D., Storch, M. K., Balatoni, B., Howard, L. M., Bornancin, F., Wlachos, A., Sobanov, J., Kinnunen, A., Baumruker, T. (2009) FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage. Brain Pathol. 19, 254-266.
195. Chun, J., Hartung, H. P. (2010) Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin. Neuropharmacol. 33, 91-101.
196. Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., Toal, M., Lynn, F., Panzara, M. A., Sandrock, A. W. (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354, 899-910.
197. Rudick, R. A., Stuart, W. H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Radue, E. W., Lublin, F. D., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., Panzara, M. A., Sandrock, A. W. (2006) Natalizumab plus interferon β-1a for relapsing multiple sclerosis. N. Engl. J. Med. 354, 911-923.
198. Major, E. O. (2009) Reemergence of PML in natalizumab-treated patients-new cases, same concerns. N. Engl. J. Med. 361, 1041-1043.
199. Jilek, S., Jaquiery, E., Hirsch, H. H., Lysandropoulos, A., Canales, M., Guignard, L., Schluep, M., Pantaleo, G., Du Pasquier, R. A. (2010) Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study. Lancet Neurol. 9, 264-272.
200. Ransohoff, R. M. (2005) Natalizumab and PML. Nat. Neurosci. 8, 1275.
201. Chen, Y., Bord, E., Tompkins, T., Miller, J., Tan, C. S., Kinkel, R. P., Stein, M. C., Viscidi, R. P., Ngo, L. H., Koralnik, I. J. (2009) Asymptomatic reactivation of JC virus in patients treated with natalizumab. N. Engl. J. Med. 361, 1067-1074.
202. Belachew, S., Phan-Ba, R., Bartholome, E., Delvaux, V., Hansen, I., Calay, P., Hafsi, K. E., Moonen, G., Tshibanda, L., Vokaer, M. (2010) Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis. Eur. J. Neurol., Epub ahead of print.
203. Sangalli, F., Moiola, L., Bucello, S., Annovazzi, P., Rizzo, A., Radaelli, M., Vitello, G., Grimaldi, L. M., Ghezzi, A., Martinelli, V., Comi, G. (2010) Efficacy and tolerability of natalizumab in relapsing-remitting multiple sclerosis patients: a post-marketing observational study. Neurol. Sci., Epub ahead of print.
204. Niino, M., Bodner, C., Simard, M. L., Alatab, S., Gano, D., Kim, H. J., Trigueiro, M., Racicot, D., Guerette, C., Antel, J. P., Fournier, A., Grand'Maison, F., Bar-Or, A. (2006) Natalizumab effects on immune cell responses in multiple sclerosis. Ann. Neurol. 59, 748-754.
205. Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmar, H. A., Lassmann, H. (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38, 788-796.
206. Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., Dijkstra, C. D. (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1033.
207. Sasseville, V. G., Newman, W., Brodie, S. J., Hesterberg, P., Pauley, D., Ringler, D. J. (1994) Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/α 4 β 1 integrin interactions. Am. J. Pathol. 144, 27-40.
208. Deloire, M. S., Touil, T., Brochet, B., Dousset, V., Caille, J. M., Petry, K. G. (2004) Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment. Mult. Scler. 10, 540-548.
209. De Vries, H. E., Hendriks, J. J., Honing, H., De Lavalette, C. R., van der Pol, S. M., Hooijberg, E., Dijkstra, C. D., van den Berg, T. K. (2002) Signal-regulatory protein α-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J. Immunol. 168, 5832-5839.
210. Bowen, M. A., Patel, D. D., Li, X., Modrell, B., Malacko, A. R., Wang, W. C., Marquardt, H., Neubauer, M., Pesando, J. M., Francke, U., et al. (1995) Cloning, mapping, and characterization of activated leukocytecell adhesion molecule (ALCAM), a CD6 ligand. J. Exp. Med. 181, 2213-2220.
211. Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., Bouthillier, A., Becher, B., Arbour, N., David, S., Stanimirovic, D., Prat, A. (2008) Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9, 137-145.
212. Kawas, C. H., Brookmeyer, R. (2001) Aging and the public health effects of dementia. N. Engl. J. Med. 344, 1160-1161.
213. Caselli, R. J., Beach, T. G., Yaari, R., Reiman, E. M. (2006) Alzheimer's disease a century later. J. Clin. Psychiatry 67, 1784-1800.
214. Kidd, M. (1963) Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197, 192-193.
215. Wisniewski, H. M., Wegiel, J., Wang, K. C., Kujawa, M., Lach, B. (1989) Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16, 535-542.
216. Rogers, J. (2008) The inflammatory response in Alzheimer's disease. J. Periodontol. 79, 1535-1543.
217. Eikelenboom, P., van Gool, W. A. (2004) Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J. Neural Transm. 111, 281-294.
218. Roher, A. E., Kuo, Y. M., Esh, C., Knebel, C., Weiss, N., Kalback, W., Luehrs, D. C., Childress, J. L., Beach, T. G., Weller, R. O., Kokjohn, T. A. (2003) Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol. Med. 9, 112-122.
219. Bell, R. D., Zlokovic, B. V. (2009) Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118, 103-113.
220. Ryu, J. K., McLarnon, J. G. (2009) A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J. Cell. Mol. Med. 13, 2911-2925.
221. Thomas, T., Sutton, E. T., Bryant, M. W., Rhodin, J. A. (1997) In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid. J. Submicrosc. Cytol. Pathol. 29, 293-304.
222. Greenberg, S. M., Gurol, M. E., Rosand, J., Smith, E. E. (2004) Amyloid angiopathy-related vascular cognitive impairment. Stroke 35, 2616-2619.
223. Glenner, G. G., Wong, C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
224. Jellinger, K. A. (2002) Alzheimer disease and cerebrovascular pathology: an update. J. Neural Transm. 109, 813-836.
225. Vinters, H. V. (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18, 311-324.
226. Kalaria, R. N. (1996) Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 72, 193-214.
227. Zlokovic, B. V. (2008) New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 5, 409-414.
228. Yang, X., Askarova, S., Lee, J. C. (2010) Membrane biophysics and mechanics in Alzheimer's disease. Mol. Neurobiol. 41, 138-148.
229. Giri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A. M., Stern, D., Kim, K. S., Zlokovic, B., Kalra, V. K. (2000) β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 279, C1772-C1781.
230. Suo, Z., Tan, J., Placzek, A., Crawford, F., Fang, C., Mullan, M. (1998) Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res. 807, 110-117.
231. Rhodin, J. A., Thomas, T. N., Clark, L., Garces, A., Bryant, M. (2003) In vivo cerebrovascular actions of amyloid β-peptides and the protective effect of conjugated estrogens. J. Alzheimers Dis. 5, 275-286.
232. Maat-Schieman, M. L., van Duinen, S. G., Rozemuller, A. J., Haan, J., Roos, R. A. (1997) Association of vascular amyloid β and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease. J. Neuropathol. Exp. Neurol. 56, 273-284.
233. Uchihara, T., Akiyama, H., Kondo, H., Ikeda, K. (1997) Activated microglial cells are colocalized with perivascular deposits of amyloid-β protein in Alzheimer's disease brain. Stroke 28, 1948-1950.
234. Giri, R., Selvaraj, S., Miller, C. A., Hofman, F., Yan, S. D., Stern, D., Zlokovic, B. V., Kalra, V. K. (2002) Effect of endothelial cell polarity on β-amyloid-induced migration of monocytes across normal and AD endothelium. Am. J. Physiol. Cell Physiol. 283, C895-C904.
235. Gonzalez-Velasquez, F. J., Moss, M. A. (2008) Soluble aggregates of the amyloid-β protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. J. Neurochem. 104, 500-513.
236. Simard, A. R., Soulet, D., Gowing, G., Julien, J. P., Rivest, S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502.
237. Itagaki, S., McGeer, P. L., Akiyama, H. (1988) Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci. Lett. 91, 259-264.
238. Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K., Kosaka, K. (2002) Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124, 83-92.
239. Town, T., Tan, J., Flavell, R. A., Mullan, M. (2005) T-cells in Alzheimer's disease. Neuromolecular Med. 7, 255-264.
240. Rogers, J., Luber-Narod, J., Styren, S. D., Civin, W. H. (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9, 339-349.
241. Yamada, M., Itoh, Y., Shintaku, M., Kawamura, J., Jensson, O., Thorsteinsson, L., Suematsu, N., Matsushita, M., Otomo, E. (1996) Immune reactions associated with cerebral amyloid angiopathy. Stroke 27, 1155-1162.
242. Monsonego, A., Zota, V., Karni, A., Krieger, J. I., Bar-Or, A., Bitan, G., Budson, A. E., Sperling, R., Selkoe, D. J., Weiner, H. L. (2003) Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 112, 415-422.
243. Antonaci, S., Garofalo, A. R., Chicco, C., Polignano, A. V., Pugliese, P., Misefari, A., Jirillo, E. (1990) Senile dementia, Alzheimer type: a distinct entity in the immunosenescence? J. Clin. Lab. Anal. 4, 16-21.
244. Man, S. M., Ma, Y. R., Shang, D. S., Zhao, W. D., Li, B., Guo, D. W., Fang, W. G., Zhu, L., Chen, Y. H. (2007) Peripheral T cells overexpress MIP-1α to enhance its transendothelial migration in Alzheimer's disease. Neurobiol. Aging 28, 485-496.
245. Li, M., Shang, D. S., Zhao, W. D., Tian, L., Li, B., Fang, W. G., Zhu, L., Man, S. M., Chen, Y. H. (2009) Amyloid β interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J. Immunol. 182, 5778-5788.
246. Liu, Y. J., Guo, D. W., Tian, L., Shang, D. S., Zhao, W. D., Li, B., Fang, W. G., Zhu, L., Chen, Y. H. (2010) Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-α-dependent. Neurobiol. Aging 31, 175-188.
247. Meigs, J. B., Hu, F. B., Rifai, N., Manson, J. E. (2004) Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291, 1978-1986.
248. Reitz, C., Tang, M. X., Schupf, N., Manly, J. J., Mayeux, R., Luchsinger, J. A. (2010) A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch. Neurol. 67, 835-841.
249. De la Monte, S. M., Wands, J. R. (2008) Alzheimer's disease is type 3 diabetes-evidence reviewed. J. Diabetes Sci. Technol. 2, 1101-1113.
250. Zuliani, G., Cavalieri, M., Galvani, M., Passaro, A., Munari, M. R., Bosi, C., Zurlo, A., Fellin, R. (2008) Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J. Neurol. Sci. 272, 164-170.
251. Borroni, B., Volpi, R., Martini, G., Del Bono, R., Archetti, S., Colciaghi, F., Akkawi, N. M., Di Luca, M., Romanelli, G., Caimi, L., Padovani, A. (2002) Peripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunction. Alzheimer Dis. Assoc. Disord. 16, 150-155.
252. Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., Kapaki, E., Vassilopoulos, D. (2004) Serum levels of soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1 in Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 17, 225-231.
253. Eikelenboom, P., Zhan, S. S., Kamphorst, W., van der Valk, P., Rozemuller, J. M. (1994) Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. Virchows Arch. 424, 421-427.
254. Verbeek, M. M., Otte-Holler, I., Wesseling, P., Ruiter, D. J., de Waal, R. M. (1996) Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the A β-containing lesions in brains of patients with dementia of the Alzheimer type. Acta Neuropathol. 91, 608-615.
255. Apelt, J., Lessig, J., Schliebs, R. (2002) β-Amyloid-associated expression of intercellular adhesion molecule-1 in brain cortical tissue of transgenic Tg2576 mice. Neurosci. Lett. 329, 111-115.
256. Frohman, E. M., Frohman, T. C., Gupta, S., de Fougerolles, A., van den Noort, S. (1991) Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease. J. Neurol. Sci. 106, 105-111.
257. Akiyama, H., Kawamata, T., Yamada, T., Tooyama, I., Ishii, T., McGeer, P. L. (1993) Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders. Acta Neuropathol. 85, 628-634.
258. Walker, D. G., Lue, L. F., Beach, T. G. (2001) Gene expression profiling of amyloid β peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22, 957-966.
259. Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., Vassilopoulos, D. (2005) The role of soluble intercellular adhesion molecules in neurodegenerative disorders. J. Neurol. Sci. 228, 129-135.
260. Nielsen, H. M., Londos, E., Minthon, L., Janciauskiene, S. M. (2007) Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiol. Dis. 26, 27-35.
261. Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., Kaye, J. A., Leszek, J., Miller, B. L., Minthon, L., Quinn, J. F., Rabinovici, G. D., Robinson, W. H., Sabbagh, M. N., So, Y. T., Sparks, D. L., Tabaton, M., Tinklenberg, J., Yesavage, J. A., Tibshirani, R., Wyss-Coray, T. (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359-1362.
262. Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C., Breteler, M. M. (2004) Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch. Neurol. 61, 668-672.
263. Wilker, E. H., Alexeeff, S. E., Poon, A., Litonjua, A. A., Sparrow, D., Vokonas, P. S., Mittleman, M. A., Schwartz, J. (2009) Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men. Atherosclerosis 206, 480-485.
264. Richter, V., Rassoul, F., Purschwitz, K., Hentschel, B., Reuter, W., Kuntze, T. (2003) Circulating vascular cell adhesion molecules VCAM-1, ICAM-1, and E-selectin in dependence on aging. Gerontology 49, 293-300.
265. Weintraub, D., Comella, C. L., Horn, S. (2008) Parkinson's disease-Part 1: pathophysiology, symptoms, burden, diagnosis, and assessment. Am. J. Manag. Care 14, S40-S48.
266. McGeer, E. G., McGeer, P. L. (2007) The role of anti-inflammatory agents in Parkinson's disease. CNS Drugs 21, 789-797.
267. Monahan, A. J., Warren, M., Carvey, P. M. (2008) Neuroinflammation and peripheral immune infiltration in Parkinson's disease: an autoimmune hypothesis. Cell Transplant. 17, 363-372.
268. Kurkowska-Jastrzebska, I., Wronska, A., Kohutnicka, M., Czlonkowski, A., Czlonkowska, A. (1999) MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. Acta Neurobiol. Exp. (Warsz.) 59, 1-8.
269. Miklossy, J., Doudet, D. D., Schwab, C., Yu, S., McGeer, E. G., McGeer, P. L. (2006) Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp. Neurol. 197, 275-283.
270. Hisanaga, K., Asagi, M., Itoyama, Y., Iwasaki, Y. (2001) Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease. Arch. Neurol. 58, 1580-1583.
271. Fiszer, U., Mix, E., Fredrikson, S., Kostulas, V., Link, H. (1994) Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood. Acta Neurol. Scand. 90, 160-166.
272. Ji, K. A., Eu, M. Y., Kang, S. H., Gwag, B. J., Jou, I., Joe, E. H. (2008) Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex. Glia 56, 1039-1047.
273. Hildebrandt, M., Amann, K., Schroder, R., Pieper, T., Kolodziejczyk, D., Holthausen, H., Buchfelder, M., Stefan, H., Blumcke, I. (2008) White matter angiopathy is common in pediatric patients with intractable focal epilepsies. Epilepsia 49, 804-815.
274. Boer, K., Jansen, F., Nellist, M., Redeker, S., van den Ouweland, A. M., Spliet, W. G., van Nieuwenhuizen, O., Troost, D., Crino, P. B., Aronica, E. (2008) Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 78, 7-21.
275. Ravizza, T., Gagliardi, B., Noe, F., Boer, K., Aronica, E., Vezzani, A. (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 29, 142-160.
276. Fabene, P. F., Navarro Mora, G., Martinello, M., Rossi, B., Merigo, F., Ottoboni, L., Bach, S., Angiari, S., Benati, D., Chakir, A., Zanetti, L., Schio, F., Osculati, A., Marzola, P., Nicolato, E., Homeister, J. W., Xia, L., Lowe, J. B., McEver, R. P., Osculati, F., Sbarbati, A., Butcher, E. C., Constantin, G. (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14, 1377-1383.
277. Bell, M. D., Perry, V. H. (1995) Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J. Neurocytol. 24, 695-710.
278. Librizzi, L., Regondi, M. C., Pastori, C., Frigerio, S., Frassoni, C., de Curtis, M. (2007) Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro. Epilepsia 48, 743-751.
279. Kim, J. V., Kang, S. S., Dustin, M. L., McGavern, D. B. (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457, 191-195.
280. Sotgiu, S., Murrighile, M. R., Constantin, G. (2010) Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. BMC Neurol. 10, 84.
281. Xu, J. H., Long, L., Tang, Y. C., Zhang, J. T., Hut, H. T., Tang, F. R. (2009) CCR3, CCR2A and macrophage inflammatory protein (MIP)-1α, monocyte chemotactic protein-1 (MCP-1) in the mouse hippocampus during and after pilocarpine-induced status epilepticus (PISE). Neuropathol. Appl. Neurobiol. 35, 496-514.
282. Manley, N. C., Bertrand, A. A., Kinney, K. S., Hing, T. C., Sapolsky, R. M. (2007) Characterization of monocyte chemoattractant protein-1 expression following a kainate model of status epilepticus. Brain Res. 1182, 138-143.
283. Louboutin, J. P., Chekmasova, A., Marusich, E., Agrawal, L., Strayer, D. S. (2010) Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage. FASEB J., Epub ahead of print.
284. Kleen, J. K., Holmes, G. L. (2008) Brain inflammation initiates seizures. Nat. Med. 14, 1309-1310.
285. Wenning, W., Haghikia, A., Laubenberger, J., Clifford, D. B., Behrens, P. F., Chan, A., Gold, R. (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N. Engl. J. Med. 361, 1075-1080.